Press Resources
Coming in Spring of 2005, the comprehensive Kogenate® FS Press Kit! If you are a member of the media, sign-up now to be notified when the Kogenate® FS Press Kit is available.
To assist the media in learning more about Kogenate® FS and in finding relevant articles or press coverage, we have compiled a series of useful links:
- The Solution: Kogenate® FS is a recombinant human factor VIII treatment (with more than 15 years of clinical experience behind it) recommended for effective treatment of patients with hemophilia A.1,2
- The Evidence: Clinical trials have demonstrated the simplicity of using the EZ-Log electronic patient diary system over paper diaries for keeping track of infusion data, as well as the safety and efficacy of Kogenate® FS in hemophilia A.
- The News: Kogenate® FS in the news.
Should you wish to get in touch with healthcare professionals, patients and scientists to discuss hemophilia treatment in general and Kogenate® FS in particular, we would be pleased to help. Let us know your interests, and we will find the right contact for you.
|
1 Medical and Safety Advisory Council of the National Hemophilia Foundation, MASAC recommendations concerning the treatment of hemophilia and other bleeding disorders. National Hemophilia Foundation. MASAC Document #151, Revised November 2003.
|
|
2United Kingdom Haemophilia Centre Doctors’ Organisation (UKHCDO). Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. Haemophilia 2003;9:1-23.
|
|
